JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that a Meeting of Board of Directors of the Company will be held on Wednesday, February 8, 2023, inter alia, to consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended December 31, 2022. As per the provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company was closed on January 1, 2023 and will remain closed until February 10, 2023. This is for your information purposes.